Status:
UNKNOWN
A Pilot Study: Preventing Adverse Remodelling Following Pacemaker Implantation
Lead Sponsor:
University of Leeds
Conditions:
Pacemakers, Heart Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Almost 40,000 people in the United Kingdom receive a new pacemaker annually. Because the pacemaker does not use the heart's normal conduction system, electrical activity from the pacemaker spreads mor...
Detailed Description
All patients booked for pacemaker clinic 6w following a new implant for heart block will receive an information sheet with their appointment letter. Potential participants will attend the National Ins...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- New RV pacemaker implant (\<6 weeks)
- Willing and able to give informed consent
- Stable medical therapy (≥6w)
- Exclusion criteria:
- Poor imaging quality
- Patients without heart block
- Guideline-mandated ACEi or ARB
Exclusion
Key Trial Info
Start Date :
December 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03422705
Start Date
December 1 2022
End Date
December 1 2022
Last Update
November 2 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.